Jennifer Kaivers
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.
Journal: British journal of haematology
Published: March 04, 2026
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission.
Journal: Transplantation and cellular therapy
Published: August 20, 2025
Outcome after Treosulfan-based conditioning in a real-world MDS cohort.
Journal: Bone marrow transplantation
Published: June 23, 2025
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries.
Journal: Leukemia
Published: December 23, 2023
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience.
Journal: Scientific reports
Published: April 14, 2023
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component.
Journal: Cancers
Published: December 02, 2022
Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies.
Journal: JCO clinical cancer informatics
Published: January 13, 2022
The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-T.
Journal: Leukemia research
Published: September 15, 2021
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Journal: Annals of hematology
Published: June 23, 2021
Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?
Journal: International journal of environmental research and public health
Published: May 25, 2021
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS.
Journal: European journal of haematology
Published: April 04, 2021
Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.
Journal: Annals of hematology
Published: March 12, 2021
Last Updated: 09/26/2026